HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicotinamide reverses deficits in puberty-born neurons and cognitive function after maternal separation.

AbstractBACKGROUND:
Early life stress (ELS) is associated with the development of schizophrenia later in life. The hippocampus develops significantly during childhood and is extremely reactive to stress. In rodent models, ELS can induce neuroinflammation, hippocampal neuronal loss, and schizophrenia-like behavior. While nicotinamide (NAM) can inhibit microglial inflammation, it is unknown whether NAM treatment during adolescence reduces hippocampal neuronal loss and abnormal behaviors induced by ELS.
METHODS:
Twenty-four hours of maternal separation (MS) of Wistar rat pups on post-natal day (PND)9 was used as an ELS. On PND35, animals received a single intraperitoneal injection of BrdU to label dividing neurons and were given NAM from PND35 to PND65. Behavioral testing was performed. Western blotting and immunofluorescence staining were used to detect nicotinamide adenine dinucleotide (NAD+)/Sirtuin3 (Sirt3)/superoxide dismutase 2 (SOD2) pathway-related proteins.
RESULTS:
Compared with controls, only MS animals in the adult stage (PND56-65) but not the adolescent stage (PND31-40) exhibited pre-pulse inhibition deficits and cognitive impairments mimicking schizophrenia symptoms. MS decreased the survival and activity of puberty-born neurons and hippocampal NAD+ and Sirt3 expression in adulthood. These observations were related to an increase in acetylated SOD2, microglial activation, and significant increases in pro-inflammatory IL-1β, TNF-α, and IL-6 expression. All the effects of MS at PND9 were reversed by administering NAM in adolescence (PND35-65).
CONCLUSIONS:
MS may lead to schizophrenia-like phenotypes and persistent hippocampal abnormalities. NAM may be a safe and effective treatment in adolescence to restore normal hippocampal function and prevent or ameliorate schizophrenia-like behavior.
AuthorsKeke Hao, Huiling Wang, Yuejin Zhang, Xinhui Xie, Huan Huang, Cheng Chen, Shilin Xu, Rui Xu, Chang Shu, Zhongchun Liu, Yuan Zhou, Gavin P Reynolds, Gaohua Wang
JournalJournal of neuroinflammation (J Neuroinflammation) Vol. 19 Issue 1 Pg. 232 (Sep 21 2022) ISSN: 1742-2094 [Electronic] England
PMID36131290 (Publication Type: Journal Article)
Copyright© 2022. The Author(s).
Chemical References
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • NAD
  • Niacinamide
  • Sirtuin 3
  • Bromodeoxyuridine
Topics
  • Animals
  • Bromodeoxyuridine (metabolism)
  • Cognition
  • Hippocampus (metabolism)
  • Interleukin-6 (metabolism)
  • Maternal Deprivation
  • NAD (metabolism, pharmacology)
  • Neurons (metabolism)
  • Niacinamide (metabolism, pharmacology)
  • Rats
  • Rats, Wistar
  • Sexual Maturation
  • Sirtuin 3
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: